Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?How long have hydroxyzine pamoate been on the market?Drugpatentwatch trametinib?Bortezomib market france?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for Dalfampridine
“Dalfampridine” itself is the generic name. It is also known by the brand name Ampyra (amifampridine is often used interchangeably in references to the same drug substance).
You may encounter both names in listings because different sources use different naming conventions or spellings for the active substance used in this therapy. In practice, they are used to refer to the same drug product class associated with Ampyra.
For a quick reference to drug substance naming and related patent/exclusivity information, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/
Other Questions About Dalfampridine :